ConductScience.org, home

Trial · NCT06076915

Usability and Feasibility of an Occupational Exergame-based Intervention

NCT06076915, Not applicable, Completed, Swiss Federal Institute of Technology

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Usability and Feasibility of an Occupational Exergame-based Intervention. Trials, record NCT06076915. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06076915

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Usability and Feasibility of an Occupational Exergame-based Intervention
NCT number
NCT06076915
Status
Completed
Phases
Not applicable
Enrollment
22 participants, actual
Lead sponsor
Swiss Federal Institute of Technology
Conditions
Healthy
Interventions
Exergame training
First posted
2023-10-11
Last updated
2023-10-11

Source ClinicalTrials.gov

Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimarySystem Usability6 weeksScore at the System Usability Scale (SUS) (for all single items and the in total) after receiving the Exergame Training for 6 weeks Higher scores imply better system usability
PrimaryTechnology Acceptance6 weeksScore at the Tailored Technology Acceptance Model (TAM) (for all single items and the in total) items after receiving the Exergame Training for 6 weeks Higher scores imply higher acceptance
PrimaryUsability6 weeksScore at the Tailored usability questionnaire items after receiving the Exergame Training for 6 weeks
PrimarySituational Motivation Scale (SIMS)6 weeks
The SIMS is a 16-item questionnaire that measures the aspects of intrinsic motivation, identified regulation, external regulation and amotivation. This brief and versatile self-report measure asks participants to rate their agree- or disagreement to predefined statements on a 7-point Likert scale.
PrimaryAdherence Rate6 weeksDuration of attended exergame training sessions in relation to the duration of the recommended (2 x 10min x 6 weeks=120 minutes) sessions (in %).
PrimaryAttrition6 weeksNumber of participants that dropped out of the study during the exergame training intervention period.
PrimaryRecruitment Rate6 weeksNumber of participating employees in relation to the total number of employees working at the company and fulfilling the inclusion/exclusion criteria at the time the study took place.
SecondaryChanges in Mental Flexibility after 6 weeks of Exergame Training (from T1 to T2 (for G1) and from T2 to T3 (for G2)6 weeks of Exergame Training
The Flexibility Test measures figural cognitive flexibility (the ability to switch between different concepts). Participants need to react as fast as possible to the presented round figure, then to the angular figure, then to the round figure and so on. Reaction times (in ms) were calculated.
SecondaryChanges in Selective Attention after 6 weeks of Exergame Training (from T1 to T2 (for G1) and from T2 to T3 (for G2)6 weeks of Exergame Training
The Arrow Test is used to measure selective attention and inhibition. A small grey dot in the middle of the screen needs to be fixated. On the right and left side of this grey dot, arrows appear, that point either to the right or left, in a randomized order. Steps then need to be performed as fast as possible in the direction where the arrowheads are pointing (and not the side where they are appearing). Reaction times (in ms) were calculated.
SecondaryChanges in Inhibition after 6 weeks of Exergame Training (from T1 to T2 (for G1) and from T2 to T3 (for G2)6 weeks of Exergame Training
The Stroop Test measures inhibition in a combination of four subtests. Four colored circles are always presented on the screen ( front=yellow, left= red, back=green, right= blue). During subtest (1), a square is presented in the middle, whereafter the circle with the matching color needs to be selected as fast as possible. During subtest (2), a word is presented in the middle, whereafter, the circle with the matching color needs to be selected as fast as possible. During subtest (3), word is presented in the middle, whereafter the circle needs to be selected, whose color matches the color of the letters. During subtest (4), a word appears in the middle, randomly either framed or not. If the word appears framed, the circle needs to be selected that matches the described color. If the word is unframed, the circle needs to be selected in the color of the word letters. Reaction times (in ms) were calculated in all subtests.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers35

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
11502012BACKGROUNDPubMed
12811274BACKGROUNDPubMed
14712852BACKGROUNDPubMed
15156087BACKGROUNDPubMed
19565283BACKGROUNDPubMed
20174982BACKGROUNDPubMed
22029804BACKGROUNDPubMed
22890825BACKGROUNDPubMed
22895372BACKGROUNDPubMed
23597658BACKGROUNDPubMed

1 to 10 of 35

See all 35 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests1

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed as
Stroop Color-Word TestSecondary outcome

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06076915

GET https://conductscience.org/api/trials/v1/NCT06076915/papers?page=2